Literature DB >> 8839170

Role of IL12 as an anti-tumour agent: current status and future directions.

M J Brunda1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8839170     DOI: 10.1016/0923-2494(96)83040-9

Source DB:  PubMed          Journal:  Res Immunol        ISSN: 0923-2494


× No keyword cloud information.
  5 in total

1.  Immune killing activity of lymphocytes on Hela cells expressing interleukin-12 in vitro.

Authors:  Huiyan Wang; Suhua Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

Review 2.  Interleukin-12 in infectious diseases.

Authors:  L Romani; P Puccetti; F Bistoni
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

3.  Cloning and characterization of an adenoviral vector for highly efficient and doxycycline-suppressible expression of bioactive human single-chain interleukin 12 in colon cancer.

Authors:  Holger Wulff; Thorsten Krieger; Karen Krüger; Ingrid Stahmer; Friedrich Thaiss; Hansjörg Schäfer; Andreas Block
Journal:  BMC Biotechnol       Date:  2007-06-26       Impact factor: 2.563

4.  Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.

Authors:  Kyung-Sun Hwang; Won-Kyung Cho; Jinsang Yoo; Hwan-Jung Yun; Samyong Kim; Dong-Soo Im
Journal:  BMC Cancer       Date:  2005-05-24       Impact factor: 4.430

5.  Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect.

Authors:  H K Koblish; C A Hunter; M Wysocka; G Trinchieri; W M Lee
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.